Return to home page
Searching: Muskingum library catalog
While many OPAL libraries have resumed lending and borrowing, some continue to operate at reduced service levels or limit in-person use to their campus community. Note that pickup services and procedures may differ between libraries. Please contact your library regarding open hours, pickup procedures, specific requests, or other assistance.
Record 1 of 2
  Previous Record Previous Item Next Item Next Record
 
COMPUTER FILE
Author Kass-Bartelmes, Barbara L.
Title Prescription drug therapies : reducing costs and improving outcomes / authors, Barbara L. Kass-Bartlemes, Lynn Bosco.
Imprint Rockville, Md. : Agency for Healthcare Research and Quality, [2002]

LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.6512/10:P 92    ONLINE  
LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.6512/10:P 92    ONLINE  
Author Kass-Bartelmes, Barbara L.
Series Research in action ; issue #8.
AHRQ pub. ; no. 02-0045.
Research in action (United States. Agency for Healthcare Research and Quality) ; issue #8.
AHRQ publication ; no. 02-0045.
Subject Prescription pricing -- United States -- Costs.
Chemotherapy -- Economic aspects -- United States.
Drug Prescriptions -- economics.
Drug Therapy -- economics.
Drug Therapy -- methods.
United States.
Alt Name Bosco, Lynn.
United States. Agency for Healthcare Research and Quality.
Description 11 pages : digital, PDF file.
polychrome rdacc
System Details Mode of access: Internet from the AHRQ web site. Address as of 3/6/08: http://www.ahrq.gov/qual/rxtherapies/rxria.pdf ; current access available via PURL.
Note Title from PDF caption (viewed Mar. 6, 2008).
"September 2002."
Bibliography Note Includes bibliographical references.
Summary The report describes Agency for Healthcare Research and Quality (AHRQ) funded research that helps to answer questions about prescription medicine. AHRQ research has identified conditions for which drug therapy is not necessary. It has discovered low-cost drug therapies that provide patients with the same quality of care as more expensive drugs. It has also revealed that sometimes the newest, most expensive drug therapy reduces costs overall because it keeps patients healthier and less likely to use other health care services. AHRQ has also finded research thatb investigated the cost effectiveness and safety of outpatient vs. inpatient services and the impact of preventive drug therapy.
OCLC # 57682710
Additional Format Prescription drug therapies 11 p. (OCoLC)51570721.


If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team